Orion OyjORINF +4.81%100 Median PS Value is $83.91 as of Jun. 26, 2026, which is 7326% above its 10-year median of 1.13. GuruFocus rates ORINF with a GF Score™ of 100/100 and a GF Value™ of $86.78. The stock has 2 warning signs investors should review. Among 544 Drug Manufacturers companies, Orion Oyj ranks worse than 63.6% on this metric.
This valuation method assumes that the stock valuation will revert to its historical (10-Year) median in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.
Median PS Value is calculated as trailing twelve months (TTM) Revenue per Share times 10-Year median PS Ratio. Orion Oyj's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 was $16.167. Orion Oyj's 10-Year median PS Ratio is 5.1902. Therefore, the Median PS Value for today is $83.91.
As of today (2026-06-26), Orion Oyj's share price is $82.75. Orion Oyj's Median PS Value is $83.91. Therefore, Orion Oyj's Price to Median PS Value for today is 0.99.
The historical rank and industry rank for Orion Oyj's Median PS Value or its related term are showing as below:
ORINF'
s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.82 Med: 1.13 Max: 1.44
Current: 0.99
During the past 13 years, the highest Price to Median PS Value of Orion Oyj was 1.44. The lowest was 0.82. And the median was 1.13.
ORINF's Price-to-Median-PS-Value is ranked worse than 63.6% of 544
companies
in the Drug Manufacturers industry
Industry Median: 0.84
vs ORINF: 0.99
Orion Oyj (OTCPK:ORINF) Median PS Value Explanation
This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio
is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.
It also assumes that over time the profit margin is constant. If a company increases its profit margin to a sustainable level, this value might under-estimate its value. If it has permanent declined profit margins, this may over-estimate the company's value.
Orion Oyj's Price to Median PS Value for today is calculated as
Price to Median PS Value
=
Share Price
/
Median PS Value
=
82.75
/
83.91
=
0.99
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Orion Oyj Median PS Value Related Terms
Orion Oyj Median PS Value Historical Data
* Premium members only.
The historical data trend for Orion Oyj's Median PS Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ORINF vs LLY, JNJ, ABBV: Median PS Value Comparison
For the Drug Manufacturers - General subindustry, Orion Oyj's Price-to-Median-PS-Value, along with its competitors' market caps and Price-to-Median-PS-Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Orion Oyj Price-to-Median-PS-Value vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Orion Oyj's Price-to-Median-PS-Value distribution charts can be found below:
* The bar in red indicates where Orion Oyj's Price-to-Median-PS-Value falls into.
10-Year Median PS Ratio is 5.1902.
Orion Oyj's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $16.167.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Orion Oyj (ORINF) has a Median PS Value of $83.91 as of Jun. 26, 2026. Median price-sales value is the stock value based on a company's 10-year median price-sales ratio, View historical data on Orion Oyj and its competitors. This is 7326% above median its historical median of 1.13. Over the past decade, Orion Oyj's Median PS Value has ranged from 0.82 to 1.44. According to the industry distribution chart, Orion Oyj ranks #346 out of 544 companies in the Drug Manufacturers industry, placing it in the top 63.6%.
Is Orion Oyj's Median PS Value too high?
Orion Oyj's current Median PS Value of $83.91 is 7326% above median its 10-year median of 1.13. Over the past 10 years, this metric has ranged from a low of 0.82 to a high of 1.44. The Drug Manufacturers industry median Median PS Value is 0.84. Orion Oyj's value of $83.91 is 9889.3% above this industry median. Based on the distribution chart, Orion Oyj ranks #346 out of 544 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, Orion Oyj has a GF Score™ of 100/100, reflecting its overall financial health beyond just this single metric.
How does Orion Oyj's Median PS Value compare to LLY and JNJ?
According to the Drug Manufacturers industry distribution chart, Orion Oyj ranks #346 out of 544 companies for Median PS Value. This places Orion Oyj in the lower half of its industry. The industry median Median PS Value is 0.84. Orion Oyj's value of $83.91 is 9889.3% above this benchmark. Historically, Orion Oyj's own Median PS Value has ranged from 0.82 to 1.44 over the past decade. While the company's 10-year median is 1.13 vs. the industry median of 0.84, Orion Oyj has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Median PS Value for a Drug Manufacturers company?
The median Median PS Value among Drug Manufacturers companies is 0.84, based on 544 companies in the industry. Companies in the top quartile (top 25%) have a Median PS Value significantly above this median, while those in the bottom quartile fall well below. However, Median PS Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Orion Oyj's current Median PS Value of $83.91 is 9889.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Median PS Value mean?
A high Median PS Value can signal that a stock is expensive relative to its fundamentals. Median price-sales value is the stock value based on a company's 10-year median price-sales ratio, View historical data on Orion Oyj and its competitors. For the Drug Manufacturers industry, the median Median PS Value is 0.84 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Orion Oyj's current Median PS Value is $83.91, which is 7326% above median its own 10-year median of 1.13. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Orion Oyj stock overvalued right now?
Orion Oyj (ORINF) has a current Median PS Value of $83.91. The stock's GF Value™ is $86.78, compared to a current price of $82.75 — trading 4.6% below its estimated fair value. The current Median PS Value is $83.91, which is 7326% above median its 10-year median of 1.13 and 9889.3% above the Drug Manufacturers industry median of 0.84. Orion Oyj's overall GF Score™ is 100/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Median PS Value calculated?
Median PS Value is calculated from a company's financial statements. For Orion Oyj (ORINF), the current Median PS Value is $83.91 as of Jun. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Orion Oyj (ORINF) Overvalued in 2026?
Based on GuruFocus' analysis, Orion Oyj stock appears to be undervalued.
The current stock price of $82.75 is trading 4.6% below its estimated GF Value™ of $86.78.
Key valuation signals for ORINF:
Median PS Value: $83.91 (7326% above median its 10-year median of 1.13)
GF Value™: $86.78 vs. price of $82.75 (4.6% below fair value)
Industry Position: 9889.3% above the Drug Manufacturers median (#346 of 544)
No single metric tells the full story. See the ORINF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Orion Oyj is a globally operating Finnish pharmaceutical company that develops, manufactures, and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients. The company predominantly focuses on treatments for central nervous system disorders, oncology, and respiratory diseases. Orion's customers include specialists and general practitioners, veterinarians, pharmacies, hospitals, and laboratories. The company mainly serves Finland but also has a presence in other European countries, North America and other countries.
100GF Score
Get the complete analysis for ORINF
Median PS Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ORINF has been successfully added to your 
